Penicillin-binding protein-mediated resistance in pneumococci and staphylococci
about
RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamasesThree decades of beta-lactamase inhibitorsStress Physiology of Lactic Acid BacteriaUse of germicides in the home and the healthcare setting: is there a relationship between germicide use and antibiotic resistance?Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitorDirect quantitation of the numbers of individual penicillin-binding proteins per cell in Staphylococcus aureus.Excretion of beta-lactam antibiotics in sweat--a neglected mechanism for development of antibiotic resistance?Towards an ontological representation of resistance: the case of MRSA.The role of bacteriolysis in the pathophysiology of inflammation, infection and post-infectious sequelae.Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections.Disease manifestations and pathogenic mechanisms of Group A Streptococcus.Identification of Salmonella enterica serovar Pullorum antigenic determinants expressed in vivo.Evolution and virulence of serogroup 6 pneumococci on a global scale.Registration of disinfectants based on relative microbicidal activity.Whole genome sequencing of penicillin-resistant Streptococcus pneumoniae reveals mutations in penicillin-binding proteins and in a putative iron permease.Reactions of peptidoglycan-mimetic beta-lactams with penicillin-binding proteins in vivo and in membranesThe use of molecular methods for the detection and identification of methicillin-resistant Staphylococcus aureus.Genomic analyses of DNA transformation and penicillin resistance in Streptococcus pneumoniae clinical isolates.A survey of methods used for antimicrobial susceptibility testing in veterinary diagnostic laboratories in the United States.Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agentsWhat we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles.Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus.Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.Antimicrobial resistance in coagulase-negative staphylococci from Nigerian traditional fermented foods.The Streptococcus pneumoniae pezAT Toxin-Antitoxin System Reduces β-Lactam Resistance and Genetic Competence.Structure-based optimization of a non-beta-lactam lead results in inhibitors that do not up-regulate beta-lactamase expression in cell cultureScreening for skin carriage of methicillin-resistant coagulase-positive staphylococci and Staphylococcus schleiferi in dogs with healthy and inflamed skin.Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.Genomic analysis and reconstruction of cefotaxime resistance in Streptococcus pneumoniae.Multi-scale strategy to eradicate Pseudomonas aeruginosa on surfaces using solid lipid nanoparticles loaded with free fatty acids.Synthesis, biological screening and molecular modeling studies of novel 3-chloro-4-substituted-1-(2-(1H-benzimidazol-2-yl)phenyl))-azetidin-2-ones.
P2860
Q24554345-B06588FE-CBC8-46FB-863D-6B31387CCA48Q24646623-DF051D81-43CA-4F3B-813A-9F80EA5E23E3Q26741272-B8007C45-D479-4158-A3F9-2CE5FBCDE491Q28265803-3E2166B2-742C-4AA5-A21D-FDA75BDD64E1Q28486539-8F75919A-0D1E-464D-898A-81B11D240AABQ31032922-96D53EBC-2E7F-4755-935E-A31742CDC7A8Q33980819-320BC063-89C7-4423-9364-44C8BC8C61A0Q34092218-FA39F842-5975-4DBF-9560-141F1B3D24C8Q34177433-973859A5-E608-4DAF-A6B7-7A4145A6A0C5Q34229656-E5D49B02-F884-4B0A-8200-04905A08D930Q34413457-071A2009-09EA-417E-9F87-25D9BB147234Q34775184-72EA23C4-90D1-48CF-96BD-0353BA26DF60Q34840451-5EAD1E93-9945-4427-B220-15D9455C7DBDQ35755953-04B1865B-B81D-4944-A3A9-48818E861918Q35907639-9DC4DFAB-9002-419E-8AA4-3B45D494559AQ36876738-FC957554-5BE3-44D9-AEC1-76716E78933EQ38268749-BAFA0A37-0F5E-4A73-A53D-7F8EC55CF5C6Q38324659-DF3456DD-6BFF-4EC3-A8A4-FAB00D8F51C4Q38370386-BA1C8A58-61D1-4AF0-840D-31945E271265Q38898545-F42EACE6-1B82-45D7-8A88-1897CCD9D05DQ39120027-A73C4276-76D7-4428-939A-B6856512EA89Q39477432-FE792610-4C66-4077-81AD-E8FC36804BE7Q40335746-B2A2CB25-9335-4B97-896D-9081B340697CQ40353121-A3F956A1-9D8A-4DCB-B48B-F3553C373186Q40546085-FE1A8965-BF40-4D69-94B0-5154E5D02FE2Q41874068-476F4AFB-CED8-45F4-8BD0-86FF34644F8CQ43806054-2F555F9C-7877-4D54-B326-6676BAB6AF51Q44814819-F8BE261D-D8CB-4C54-B340-71D93FCC8005Q51051543-F3B576AB-8129-483B-9A00-8D77ABCF5AFEQ51771060-4D787A4E-A25E-4DAF-9E88-1ACED3E38FCFQ54355299-817DA914-B7F5-4A99-A01C-C08AF81CE1A8
P2860
Penicillin-binding protein-mediated resistance in pneumococci and staphylococci
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Penicillin-binding protein-mediated resistance in pneumococci and staphylococci
@ast
Penicillin-binding protein-mediated resistance in pneumococci and staphylococci
@en
Penicillin-binding protein-mediated resistance in pneumococci and staphylococci
@nl
type
label
Penicillin-binding protein-mediated resistance in pneumococci and staphylococci
@ast
Penicillin-binding protein-mediated resistance in pneumococci and staphylococci
@en
Penicillin-binding protein-mediated resistance in pneumococci and staphylococci
@nl
prefLabel
Penicillin-binding protein-mediated resistance in pneumococci and staphylococci
@ast
Penicillin-binding protein-mediated resistance in pneumococci and staphylococci
@en
Penicillin-binding protein-mediated resistance in pneumococci and staphylococci
@nl
P3181
P356
P1476
Penicillin-binding protein-mediated resistance in pneumococci and staphylococci
@en
P2093
H F Chambers
P304
P3181
P356
10.1086/513854
P407
P478
179 Suppl 2
P577
1999-03-01T00:00:00Z